Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Research analysts at Ventum Cap Mkts decreased their FY2025 earnings estimates for Cresco Labs in a research note issued on Wednesday, March 12th. Ventum Cap Mkts analyst A. Semple now forecasts that the company will earn ($0.09) per share for the year, down from their previous forecast of ($0.08). The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share.
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last issued its quarterly earnings results on Friday, March 14th. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01). Cresco Labs had a negative net margin of 9.15% and a negative return on equity of 16.52%. The business had revenue of $176.00 million during the quarter, compared to the consensus estimate of $172.10 million.
Read Our Latest Stock Analysis on Cresco Labs
Cresco Labs Price Performance
Shares of CRLBF stock opened at $0.75 on Monday. The company has a current ratio of 1.97, a quick ratio of 1.39 and a debt-to-equity ratio of 1.80. Cresco Labs has a twelve month low of $0.70 and a twelve month high of $2.60. The firm has a fifty day simple moving average of $0.89 and a 200-day simple moving average of $1.20. The company has a market capitalization of $364.25 million, a PE ratio of -3.73 and a beta of 1.79.
Cresco Labs Company Profile
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Further Reading
- Five stocks we like better than Cresco Labs
- How to start investing in penny stocks
- How to Build the Ultimate Everything ETF Portfolio
- Investing In Preferred Stock vs. Common Stock
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Where Do I Find 52-Week Highs and Lows?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.